Host response to the lung microbiome in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 4, 2015, Pages 438-445

  Sze, Marc A ^a,b   Dimitriu, Pedro A ^b   Suzuki, Masaru ^a,c   McDonough, John E ^a,b   Campbell, Josh D ^d   Brothers, John F ^d   Erb Downward, John R ^e   Huffnagle, Gary B ^e   Hayashi, Shizu ^a,c   Elliott, W Mark ^a,b   Cooper, Joel ^f   Sin, Don D ^a,b   Lenburg, Marc E ^d   Spira, Avrum ^d   Mohn, William W ^b   Hogg, James C ^a,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bacteria; COPD; Inflammation; Microbiome

Indexed keywords

DNA 16S;

ACTINOBACTERIA; ADULT; ARTICLE; B LYMPHOCYTE; BACTEROIDALES; BACTEROIDETES; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELIZABETHKINGIA MENINGOSEPTICA; EOSINOPHIL; FEMALE; FIRMICUTES; FLAVOBACTERIUM; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG; LUNG PARENCHYMA; MALE; MICROBIAL DIVERSITY; MICROBIOME; NEUTROPHIL; NONHUMAN; PORPHYROMONAS; PREVOTELLA; PREVOTELLA ORALIS; PRIORITY JOURNAL; PROTEOBACTERIA; PYROSEQUENCING; STREPTOCOCCUS; BRONCHIOLE; CASE CONTROL STUDY; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

BRONCHIOLES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; NEUTROPHIL INFILTRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84938612864     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201502-0223OC     Document Type: Article

References (37)

1. World Health Organization (WHO). The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press; 2008.
2. Baraldo S, Turato G, Saetta M. Pathophysiology of the small airways in chronic obstructive pulmonary disease. Respiration 2012;84:89-97.
3. Di Stefano A, Turato G, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, Boschetto P, Fabbri LM, Saetta M. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med 1996;153:629-632.
4. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
5. Fletcher CM. Chronic bronchitis: its prevalence, nature, and pathogenesis. Am Rev Respir Dis 1959;80:483-494.
6. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648.
7. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471.
8. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
9. Li K, Bihan M, Methé BA. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS ONE 2013;8:e63139.
10. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, Methé BA, Huttenhower C. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol 2012;10:e1001377.
11. Conlan S, Kong HH, Segre JA. Species-level analysis of DNA sequence data from the NIH Human Microbiome Project. PLoS ONE 2012;7:e47075.
12. Morgan XC, Segata N, Huttenhower C. Biodiversity and functional genomics in the human microbiome. Trends Genet 2013;29:51-58.
13. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010;5:e8578.
14. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS ONE 2011;6:e16384.
15. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1073-1080.
16. Sze M, Dimitriu PA, Suzuki M, McDonough JE, Campbell JD, Brothers JF, Hayashi S, Elliott WM, Cooper J, Sin DD, et al. The host response to the bacterial lung tissue microbiome in chronic obstructive pulmonary disease [abstract]. Am J Respir Crit Care Med 2014;189:A1012.
17. Sze M, Erb-Downward JR, Hayashi S, Elliott WM, Sin DD, Huffnagle GB, Hogg JC. Is there a difference? A comparison between a nested and touchdown PCR approach for bacterial microbiome analysis [abstract]. Am J Respir Crit Care Med 2014;189:A4969.
18. Sze M, Dimitriu PA, McDonough JE, Suzuki M, Gosselink JV, Elliott MW, Mohn WW, Sin DD, Hayashi S, Hogg JC. The host response to the lung microbiome during emphysematous destruction [abstract]. Am J Respir Crit Care Med 2013;187:A3493.
19. Sze M, Dimitriu PA, Suzuki M, McDonough JE, Gosselink JV, Elliott MW, Mohn WW, Sin DD, Hayashi S, Hogg JC. Host response to the lung microbiome in lung tissue undergoing emphysematous destruction [abstract]. Ann Am Thorac Soc 2014;11:S77.
20. Gosselink JV, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Paré PD, Pierce JA, et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:1329-1335.
21. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-1575.
22. Campbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, Suzuki M, Gosselink JV, Liu G, Alekseyev YO, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med 2012;4:67.
23. Ward DV, Gevers D, Giannoukos G, Earl AM, Methé BA, Sodergren E, Feldgarden M, Ciulla DM, Tabbaa D, Arze C, et al.; Jumpstart Consortium Human Microbiome Project Data Generation Working Group. Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS ONE 2012;7:e39315.
24. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 2011;6:e27310.
25. Korbie DJ, Mattick JS. Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat Protoc 2008;3:1452-1456.
26. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, et al.; Lung HIV Microbiome Project. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 2013;187:1067-1075.
27. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS ONE 2014;9:e97214.
28. McArdle BH, Anderson MJ. Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology 2001;82:290-297.
29. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:3.
30. Kursa MB, Rudnicki WR. Feature selection with the Boruta package. J Stat Softw 2010;36:1-13.
31. Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci 2003;14:927-930.
32. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS ONE 2012;7:e47305.
33. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014;12:87.
34. Lysenko ES, Ratner AJ, Nelson AL, Weiser JN. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog 2005;1:e1.
35. Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996;9:18-33.
36. Nakou A, Papaparaskevas J, Diamantea F, Skarmoutsou N, Polychronopoulos V, Tsakris A. A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease. Future Microbiol 2014;9:1251-1260.
37. Aydemir Y, Aydemir Ö, Kalem F. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation. Int J Chron Obstruct Pulmon Dis 2014;9:1045-1051.